570 results on '"Barbet, Jacques"'
Search Results
2. New Advances in Radioimmunotherapy for the Treatment of Cancers
3. Chimeric antibody c.8B6 to O-acetyl-GD2 mediates the same efficient anti-neuroblastoma effects as therapeutic ch14.18 antibody to GD2 without antibody induced allodynia.
4. New Advances in Radioimmunotherapy for the Treatment of Cancers
5. Coupling a gamma-ray detector with asymmetrical flow field flow fractionation (AF4): Application to a drug-delivery system for alpha-therapy
6. Cancers, vers une révolution thérapeutique ?
7. Translational molecular imaging in exocrine pancreatic cancer
8. Consolidation anti-CD22 fractionated radioimmunotherapy with 90Y-epratuzumab tetraxetan following R-CHOP in elderly patients with diffuse large B-cell lymphoma: a prospective, single group, phase 2 trial
9. New Advances in Radioimmunotherapy for the Treatment of Cancers
10. Pretargeting in the context of theranostics and companion diagnostics in nuclear oncology
11. Pretargeting for imaging and therapy in oncological nuclear medicine
12. 211At-labeled agents for alpha-immunotherapy: On the in vivo stability of astatine-agent bonds
13. Medullary Thyroid Carcinoma
14. Cyclotron-Based Radiopharmaceuticals for Nuclear Medicine Therapy
15. Covalent Coupling Of Monoclonal Antibodies and Protein A To Liposomes: Specific Interaction With Cells In Vitro and In Vivo
16. 90Y-labelled anti-CD22 epratuzumab tetraxetan in adults with refractory or relapsed CD22-positive B-cell acute lymphoblastic leukaemia: a phase 1 dose-escalation study
17. Medullary Thyroid Carcinoma
18. Applications of Near-field Microscopes to Cell Biology
19. 18F-FDG PET predicts survival after pretargeted radioimmunotherapy in patients with progressive metastatic medullary thyroid carcinoma
20. Calculating an estimate of tissue integrated activity in 18F-FDG PET imaging using one SUV value
21. Assessment of acquisition protocols for routine imaging of Y-90 using PET/CT
22. Copper-64-Labeled 1C1m-Fc, a New Tool for TEM-1 PET Imaging and Prediction of Lutetium-177-Labeled 1C1m-Fc Therapy Efficacy and Safety
23. Liposome Delivery of Cyclic AMP-Dependent Protein Kinase Inhibitor into Intact Cells: Specific Blockade of Cyclic AMP-Mediated Adrenocorticotropin Release from Mouse Anterior Pituitary Tumor Cells
24. DNA Polyintercalating Drugs: DNA Binding of Diacridine Derivatives
25. Corticotropin-Releasing Factor-Induced Adrenocorticotropin Hormone Release and Synthesis is Blocked by Incorporation of the Inhibitor of Cyclic AMP-Dependent Protein Kinase into Anterior Pituitary Tumor Cells by Liposomes
26. Differential Endocytosis of T and B Lymphocyte Surface Molecules Evaluated with Antibody-Bearing Fluorescent Liposomes Containing Methotrexate
27. Pretargeted radioimmunotherapy: clinically more efficient than conventional radioimmunotherapy?
28. New Advances in Radioimmunotherapy for the Treatment of Cancers
29. dAcquisition setting optimization and quantitative imaging for 124I studies with the Inveon microPET-CT system
30. Pretargeted radioimmunotherapy (pRAIT) in medullary thyroid cancer (MTC)
31. Dosimetry results suggest feasibility of radioimmunotherapy using anti-CD138 (B-B4) antibody in multiple myeloma patients
32. Syndecan-1 antigen, a promising new target for triple-negative breast cancer immuno-PET and radioimmunotherapy. A preclinical study on MDA-MB-468 xenograft tumors
33. Pretargeted radioimmunotherapy of colorectal cancer metastases: models and pharmacokinetics predict influence of the physical and radiochemical properties of the radionuclide
34. ARRONAX, a high-energy and high-intensity cyclotron for nuclear medicine
35. Consolidation radioimmunotherapy of follicular lymphoma: a step towards cure?
36. Prospective comparison of two gamma probes for intraoperative detection of 18F-FDG: in vitro assessment and clinical evaluation in differentiated thyroid cancer patients with iodine-negative recurrence
37. Initial Clinical Results of a Novel Immuno-PET Theranostic Probe in HER2-negative Breast Cancer
38. Which radionuclides will nuclear oncology need tomorrow?
39. Generation of llama single-domain antibodies against methotrexate, a prototypical hapten
40. Improved pretargeted delivery of radiolabelled hapten to human tumour xenograft in mice by avidin chase of circulating bispecific antibody
41. Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study
42. Impact of DOTA Conjugation on Pharmacokinetics and Immunoreactivity of [177Lu]Lu-1C1m-Fc, an Anti TEM-1 Fusion Protein Antibody in a TEM-1 Positive Tumor Mouse Model
43. Radioimmunotherapy: Is avidin-biotin pretargeting the preferred choice among pretargeting methods?
44. Medullary Thyroid Carcinoma
45. Medullary Thyroid Carcinoma
46. Cyclotron-Based Radiopharmaceuticals for Nuclear Medicine Therapy
47. Radiolabeled Antibodies for Cancer Imaging and Therapy
48. Rhenium-188-labeled anti-neural cell adhesion molecule antibodies with 2-iminothiolane modification for targeting small-cell lung cancer
49. The best radionuclide for radioimmunotherapy of small tumors: beta- or alpha-emitter?
50. The intraportal injection model for liver metastasis: advantages of associated bioluminescence to assess tumor growth and influences on tumor uptake of radiolabeled anti-carcinoembryonic antigen antibody
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.